GASTROENTEROLOGY & PANCREATICOBILIARY

Our Gastroenterology and Pancreaticobiliary research program is dedicated to advancing the understanding, diagnosis, and treatment of disorders affecting the digestive system. Our work spans a broad spectrum of conditions and mechanisms related to the gastrointestinal (GI) tract and associated organs, including the pancreas, liver, gallbladder, and bile duct.

Research in this field has played a critical role in improving outcomes for patients suffering from complex digestive diseases. Recent advances in molecular biology, genetics, and imaging technologies have enabled our scientists and partners to uncover the biological underpinnings of GI disorders, facilitating the development of more precise diagnostics, targeted therapies, and preventive strategies.

gastroenterology

We focus on a variety of digestive conditions, including:

  • Crohn's Disease
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Pancreatitis
  • Hepatobiliary Diseases
  • Gastroesophageal Reflux Disease (GERD)
  • Colorectal and Pancreatic Cancers

A significant area of our current focus is the gut microbiome—the complex community of microbes that live in the digestive tract. Emerging research has shown that imbalances in the microbiome are linked to a range of conditions, from inflammatory bowel disease (IBD) to colorectal cancer. We are actively involved in studies exploring how microbiome alterations and external factors—such as diet, environment, and medications like antibiotics—influence disease onset and progression.

Through innovative, patient-centric clinical trials, Tupalin Research is helping to shape the future of gastroenterology care by supporting therapies that are more effective, personalized, and aligned with the biological complexity of digestive health.

Specialized Capabilities in Gastroenterology Trials

Our team brings deep expertise and a robust infrastructure tailored specifically to the complex needs of gastroenterology and pancreaticobiliary clinical trials. We follow standardized, industry-leading processes to ensure high-quality execution, regulatory compliance, and reliable outcomes.

Our specialized services include:

  • Central Laboratory Services

    • Comprehensive lab support with validated assays and biomarker capabilities for GI and liver-related studies.

  • Electronic Data Capture (EDC)

    • Secure and efficient digital platforms for real-time data collection, monitoring, and analysis, ensuring data accuracy and integrity.

  • IVRS/IWRS Systems

    • Integrated Interactive Voice and Web Response Systems for seamless randomization, drug supply management, and patient tracking.

  • Advanced Imaging Systems

    • High-resolution imaging tools and standardized protocols for evaluating disease progression and treatment response in GI trials.

  • CTMS

    • Industry-standard Clinical Trial Management System for centralized trial oversight, site management, and regulatory documentation.

Our streamlined processes and technology-driven approach enable faster trial startup, improved patient recruitment, and high-quality data delivery. With us, sponsors can expect precision, transparency, and performance at every stage of the gastroenterology trial lifecycle.